Results 111 to 120 of about 1,785 (194)

Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective.

, 2019
Background: Community-acquired bacterial pneumonia (CABP) is an acute, lower respiratory bacterial infection. Despite advances in medical care, CABP remains associated with considerable morbidity, mortality, and healthcare costs; early empiric treatment ...
LaPensee, Kenneth, Mistry, Rohit, Lodise, Thomas P   +2 more
core  

Early diagnosis and therapy of Chlamydia psittaci pneumonia: insights from chest CT, tNGS, and omadacycline in 34 cases. [PDF]

Front Med (Lausanne)
Jiang Q, Zhao X, Zhu Y, Zhu X, Hu S, Zhou H.   +5 more
europepmc   +1 more source

Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections.

, 2019
Background: Omadacycline is an oral and intravenous (IV) once-daily aminomethylcycline antibiotic that is approved in the United States for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSI).
LaPensee, Kenneth, Mistry, Rohit, Lodise, Thomas P   +2 more
core  

Omadacycline vs other Tetracyclines: A novel drug against Vancomycin Resistant Enterococcus

Vancomycin-resistant enterococci (VRE) are multidrug-resistant pathogens, associated with substantial morbidity and mortality having limited therapeutic options.
Taval, Shashidharamurthy, Mohar, Natasha, Ali, Sumaiyya, Mody, Vicky   +3 more
core   +1 more source

Omadacycline for peritoneal dialysis-associated peritonitis caused by <i>Coxiella burnetii</i>: a case report and literature review. [PDF]

Front Med (Lausanne)
Hong X, Cai Z, Yu Z, Fu H, Cai J, Wu Z, Wu X, Kuang Z.   +7 more
europepmc   +1 more source

Compassionate Use of Omadacycline in a Down Syndrome Pre-Schooler With Critically Ill Atypical Pneumonia Caused by Macrolide-Resistant Mycoplasma Pneumoniae [PDF]

Di Wu,1,* Feng-Jie Xie,2,* Ya-Jun Wang,3,* Xiao-Hui Jiang,1,* Guo-Li Zhang,3,* Hong Zhang,2 Yu-Cheng Zhu,4 Yan Zhang,4 Yu-Jia Tang,1 Yi-Lu Lin,1 Jia-Xi Xu,5 Jia-Ning Zhang,5 Bo-Wen Liu,5 Kai Kang,5 Yang Gao1 1Department of Critical ...
Zhu YC, Tang YJ, Zhang H, Lin YL, Wu D, Zhang GL, Zhang JN, Wang YJ, Xie FJ, Liu BW, Zhang Y, Gao Y, Xu JX, Jiang XH, Kang K   +14 more
core  

Zebrafish larvae swim bladder serves as a model to study Mycobacterium abscessus infection kinetics, host-pathogen interactions and drug efficacy. [PDF]

Mycobacteria
Basnet RM, Gupta S, Olivier KN.
europepmc   +1 more source

Coagulation dysfunction events associated with novel tetracycline-class drugs: a disproportionality and Bayesian analysis based on the FAERS database. [PDF]

Front Antibiot
Li H, Wang J, Kong L, Wei Q, Shen C, Zou D.   +5 more
europepmc   +1 more source

Clinical Efficacy and Safety of Omadacycline Versus Tigecycline in Treating Severe Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacilli: A Retrospective Cohort Study

Infection and Drug Resistance
Ye Zhang,1 Fei Wang,2 Min Wang,1 Wenhui Xu,3 Aiping Wang,3 Yueping Ding2 1Department of Pharmacy, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Intensive Care Unit ...
Zhang Y, Wang F, Wang M, Xu W, Wang A, Ding Y   +5 more
doaj  

Efficacy, Safety, and in vitro Sensitivity of Omadacycline in the Treatment of Brucellosis: A Case Series Study. [PDF]

Infect Drug Resist
Zeng Z, Tan H, Wu B, Jiang Q, Ye Y, Zhang Y, Wu Y, Yu Y, Zhou H.   +8 more
europepmc   +1 more source